Platelet Rich Plasma Therapy and lower back pain

Ross Hauser, MD

Many people who reach out to our center looking for options for their low back pain have done a lot of research on the various remedies available to them. This research probably came as the result of years of trial and error pain management of their low back problems. Therefore, by the time many people reach out to us, they already have had a long history of treatments for their back pain including self-administered over-the-counter medication, various back braces and belts, online yoga or Pilates classes, or exercise techniques. When their back pain worsened and became more chronic and painfully acute, medical attention was sought. Now the medication came in prescription dosage, the exercise became physical therapy (Please see our article Why physical therapy and yoga did not help your low back pain), and eventually, cortisone or epidural steroid injection may be recommended.

Along with these treatments came an MRI which may have been inconclusive or conclusive enough to suggest or not suggest surgery, please see our article: Is your MRI or CT Scan sending you to a back surgery you do not need? Eventually, a diagnosis of Degenerative Disc Disease, bulging or herniated disc(s), lumbar stenosis, lumbar spondylolisthesis, SI Joint dysfunction, and sciatica is made.

The treatment of PRP or Platelet Rich Plasma Therapy is considered a controversial treatment with the controversy surrounding the actual effectiveness of the treatment and how the treatment is applied. In one application the PRP solution is injected directly into the flattened disc. In another application, the treatment is given to the facet joint and the ligament attachments that provide the spine stability. It is well documented that flattened discs do not flatten on their own, the loss of disc height is the cumulative effect of degenerative joint disease from spinal instability caused by a chronic back sprain or ligament weakness, laxity, and damage.  Solving the problem of persistent low back pain, in some patients, may be as simple as treating chronic spinal ligament sprain as opposed to spinal surgical intervention. PRP may be an option.

What is PRP, and how is it used in treating back pain patients?

the loss of disc height is the cumulative effect of degenerative joint disease from spinal instability caused by a chronic back sprain or ligament weakness, laxity, and damage

PRP is an injection with an injectable solution derived from your own blood. To create this solution, a small sample of your blood is drawn, similar to a lab-test blood draw.

  • Your blood platelets contain growth and healing factors. When concentrated through simple centrifuging, your blood plasma becomes “rich” in healing factors, thus the name Platelet RICH plasma. Platelets play a central role in injury healing.
  • The procedure and preparation of therapeutic doses of growth factors consist of autologous blood collection (blood from the patient), plasma separation (blood is centrifuged), and application of the plasma rich in growth factors (injecting the plasma into the area.)

The PRP can then be injected in two ways.

  • Into the facet or spinal joint areas to strengthen the connective tissue to provide spinal stability and eventually alleviate pressure on the disc.
  • Into the disc itself.

This idea of injecting directly into the disc is one of the controversial aspects of PRP treatments for lower back pain. It is easy for patients to get excited about the prospect of intradiscal injections for their back pain because the idea is simple. Inject the disc, restore disc height alleviate pressure in the spine. Results are inconsistent.

What are we seeing in this image? Injections into joints, not the discs.

In addition to PRP therapy, we offer Prolotherapy treatments. Prolotherapy injections are composed of simple dextrose as opposed to blood platelet concentration. In our office, we do not offer PRP injections into the back as a stand-alone treatment. It is used in conjunction with Prolotherapy. The point of the illustration below is to demonstrate the areas where we give PRP and Prolotherapy injections. Not into the disc, but into and surrounding the injured facet capsular, sacroiliac, and other ligaments that impact stability in the lumbar region.

The point of the illustration below is to demonstrate the areas where we give PRP and Prolotherapy injections. Not into the disc, but into and surrounding the injured facet capsular, sacroiliac and other ligaments that impact stability in the lumbar region.

Current research on the use of PRP in treating low back pain patients

A February 2024 study published in the journal Cureus (1) gives an overview of the current research on the use of PRP for low back pain: “For those with low back pain, autologous Platelet Rich Plasma spinal injections have demonstrated efficacy and safety as a conservative treatment option. Furthermore, compared to steroids, autologous PRP is a better therapeutic option due to its longer-lasting effectiveness, according to the research. Numerous studies have provided evidence regarding the safety and potential short- and long-term effects of platelet-rich products and PRP in the treatment of low back pain.”

A September 2023 paper published in the journal Biomedicines (2) shows: “Evidence has consistently demonstrated that PRP therapy offers a less invasive and safe alternative for the treatment of chronic low back pain. Notably, the use of PRP has shown significant benefits without substantial side effects or complications. The authors also stressed the importance of multi-injections. They describe one of their important findings: “(we) advocate for the application of injections in multiple sites rather than targeting a single area. It is well established that there is a strong relationship between disc degenerative disease and facet arthrosis (degenerative arthritis).  Furthermore, it is common to observe simultaneous degenerative lesions in real-world patients. (A whole facet joint breakdown). Therefore, the rationale behind treating patients with multiple targets is justifiable.”

A study from May 2020 in the Journal of Neurological Surgery. Part A, Central European Neurosurgery (3) conducted an analysis of previously published research to help answer the question and controversial results of treatment.  The research team examined three randomized clinical trials involving 131 patients. What they found was PRP injection reduced pain scores significantly in a subgroup of these patients some with more than 50% pain relief at 3 months.

Platelet-rich plasma versus corticosteroids in the treatment of synovitis and radiculopathy

A published November 2022 study (4) examined the role of intra-articular injection of platelet-rich plasma versus corticosteroids in the treatment of synovitis in lumbar facet joint disease. In this study, 30 patients with lumbar facet joint disease, divided into two equal groups, received PRP and corticosteroid injections. Patients were comparatively assessed. Both groups showed a significant improvement in pain, function, and synovitis at follow-up after 3 months. The PRP injections group however promoted better performance in terms of MRI synovitis grade in all lumbar facet joint disease levels compared to corticosteroid injections.

In August 2022, researchers in the Turkish Journal of Physical Medicine and Rehabilitation (5) compared platelet-rich plasma and corticosteroid injection under epiduroscopic guidance for radiculopathy in patients who did or did not have surgery for lumbar disc herniation. This retrospective study was conducted with 62 patients. Of the patients, 32 did not have surgery, whereas 30 patients did have surgery. With evaluations by phone at 10 days, one month, and six months, the study suggested “both PRP and corticosteroid injections were effective in pain scores during short-term and long-term follow-ups.

Doctors at the University of Oklahoma Health Sciences Center and Louisiana State University wrote in an October 2022 (6) review of previously published research: “To date, well-designed case-control or cohort studies for the use of PRP have demonstrated efficacy in lumbar facet joint, lumbar epidural, and sacroiliac joint injections.  . . numerous studies have evaluated PRP to steroid injections in chronic pain states with favorable results. PRP represents an opportunity for a new strategy in the therapeutic treatment of degenerative states of spines, joints, and other locations throughout the body with evolving data demonstrating both safety and long-term efficacy.” The authors also cited the need for more high-level research to confirm these earlier findings.

Transforaminal steroid injection vs PRP Injections

Transforaminal steroid injection vs PRP Injections

The above caption reads: A transforaminal epidural steroid injection requires the very precise placement of the needle into the spinal canal from the side. This allows the injected solution to travel around the area of nerve entrapment.

A May 2021 study (7) published in the journal Neural Plasticity compared outcomes in PRP vs Transforaminal steroid injection patients who suffer from radicular pain due to lumbar disc herniation.

In a randomized controlled trial, ultrasound-guided transforaminal injections of either PRP (in 61 patients) or steroid (in 63 patients) were administered. The results showed similar outcomes for both transforaminal injections using PRP and steroids in the treatment of lumbar disc herniation, suggesting the possible application of PRP injection as a safer alternative.

An April 2023 study published in the journal BMC Musculoskeletal Disorders (8) looked at the outcomes of thirty patients, fifteen patients being treated with triamcinolone and fifteen patients treated with PRP. Each of the patients had pain and disability scores recorded at the onset of treatment and at 2, 6, 12, and 24 weeks.

The patient report outcomes of the PRP group showed a statistically and clinically significant reduction in pain and disability scores at 6, 12, and 24 weeks yielding superior results to triamcinolone.

A February 2024 double-blinded randomized controlled trial (9)  compared the outcomes of epidural steroids with those of PRP in single dermatomal lumbar radiculopathy caused by prolapse lumbar intervertebral disc. The results of the follow-up of the PRP group were inferior to that in the steroid group after 1 week, comparable with the steroid group at 3 weeks, and better than the steroid groups in patient-reported outcome scores at 6 weeks.

Is injecting directly into the disc better or equal to treating the surrounding disc area?

A discussion of both injections into the facet joint and into the disc itself was covered

A February 2021 paper (10) had an international team of doctors explore the various aspects of PRP for low back pain. A discussion of both injections into the facet joint and into the disc itself was covered. Here are some of the paper’s learning points:

Facet joints have been implicated in 40% of cases of spine pain. However, the researchers noted that at the time of their study’s publication, only three studies that investigated the results of PRP injections into the facet joints and the surrounding ligaments had been published.

In one study of five patients:  “PRP was injected into the facet joints, capsule, supraspinous, and infraspinous ligaments under ultrasound or fluoroscopic guidance. All five cases reported a significant improvement in their pain. However, given the absence of a control group, it is not possible to conclude whether this treatment is better or worse than the established modalities.”

Another study enrolled 19 patients with lumbar facet joint syndrome and injected autologous PRP into the lumbar facet joints under X-ray fluoroscopic guidance. Significant pain reduction was experienced by nine patients (47.37%) immediately after treatment, 14 (73.68%) at 1 week, and 15 patients (78.95%) at one month, two months, and three months.

In 2017, a prospective comparative study randomized 46 patients into group A (intra-articular PRP injections) and group B (intra-articular local anesthetic and corticosteroid . . . Both groups achieved statistically significant pain relief. In the steroid group, improvement peaked (85%) after 1 month, but it was only 20% after 6 months. However, the PRP group achieved better results over time leading to the conclusion that PRP is a superior treatment option for longer duration effectiveness.

In regard to PRP into the disc, the researchers found PRP to be a feasible treatment to counter disc degeneration associated with low back pain. But: “It is vital to administer PRP early in the course of the treatment to stimulate the growth of the remaining cells in the disc. If the treatment is delayed, the number of active cells in the disc will be at a minimum and the PRP will possibly fail to induce the desired impact. Although intradiscal PRP injections show promising results, there is a need for more studies with larger sample sizes and adequate control groups. Further studies are also needed to define the subset of patients most likely to benefit from this treatment.”

This is basically the same reasoning we suggested above. Generally, if a patient has long-term chronic back pain and degenerative disc disease, the likelihood of a good outcome of intramuscular treatment is diminished. In our opinion treatments into the facet joint and capsular joints could provide enough stability in the spine to allow the disc to restore its height over time naturally. Further, a flattened disc may not be the primary cause of the patient’s low back pain. The ligaments themselves are highly sensitive to pain. It may be the ligaments themselves who are the leading pain culprits.

An October 2022 paper published in the journal BioMed Research International (11) aimed at evaluating the effectiveness of autologous PRP on discogenic low back pain at 48 weeks postinjection in patients who received a single intradiscal injection.

In these patients, lumbar function and adverse events were assessed at 1 week, 4 weeks, 8 weeks, 12 weeks, 24 weeks, and 48 weeks post-injection and compared to the pre-injection values.  Compared to pre-injection, pain, and lumbar function were significantly improved, and there were significant differences over the 48-week follow-up. Twenty-two (71%) patients were classified as successes after the intradiscal injection of PRP. One patient received surgery at two weeks post-injection due to intervertebral discitis. . . Further randomized controlled clinical trials are needed to assess the effects of this injection therapy.

Placement of PRP close to the disc puts a high amount of growth factors and cytokines at the site of collagen injury and degenerated disc.

Doctors at the Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences wrote in their March 2023 (12) published results evaluating the effectiveness of PRP on low back pain in patients with prolapsed intervertebral disc, “PRP provided sustained relief from low back pain due to prolapsed intervertebral disc and can be recommended as a safe and promising alternative to epidural local anaesthetics and steroids.” They also write that this success can be attributed to the “placement of PRP close to the disc (which) puts a high amount of growth factors and cytokines at the site of collagen injury and degenerated disc.”

In this comparison study, the doctors divided low back pain patients into two groups. Twenty-one patients would receive PRP therapy. Twenty-one patients would receive epidural local anesthetics with steroids.

At six months the epidural group saw an average 26.45% pain reduction as compared to baseline pain, the PRP group showed a 79.31%, pain reduction.

The clinical effectiveness of transforaminal steroid and platelet-rich plasma (PRP) injections

A May 2023 paper (13) from doctors at the Teerthanker Mahaveer Medical College and Research Centre in India, compares the clinical effectiveness of transforaminal steroid and platelet-rich plasma (PRP) injections in patients with discogenic lumbar radiculopathy in a study group of 60 patients. PRP was given in 29 patients, and steroid (methylprednisolone acetate) in 31 patients.

Both groups showed initial significant statistical improvement as measured by Visual Analog Pain scores and Modified Oswestry Low Back Pain Disability Index scores. The difference between the two groups was that improvement was seen in the PRP group at one, three, and six months, whereas the steroid group only showed improvement in one and three months after treatment. improvements sustaining for 6 months were provided by PRP only.

PRP outcomes in 67 patients with low back pain

A 2019 paper in the journal Cogent Medicine (14) demonstrated PRP outcomes in 67 patients with low back pain. Here are the study’s summary findings:

  • 67 patients had a series of one-, two, or three PRP injections into the ligaments, muscle, and fascia surrounding the lumbar spine.
  • Patients who received two treatments received injections an average of 24 days apart and patients who received three treatments received injections an average of 20.5 days apart.

Outcomes:

  • Patients who received one PRP injection reported 36.33% overall improvement and experienced significant improvements in active pain relief.
  • Patients who received a series of two treatments experienced significant decreases in resting pain and active pain and reported 46.17% total overall improvement respectively.
  • Patients who received three treatments experienced significant decreases in resting pain and active pain and reported  54.91% total overall improvement respectively.
  • In addition, they were able to perform daily activities with less difficulty than prior to treatment. This study demonstrated that one, two, or three PRP treatments were effective in significantly reducing active pain in the lower back. Additionally, functionality scores were significantly increased showing that patients were able to quickly return to everyday activities.

Mechanical and functional spinal instability

What are we seeing in this image? The caption reads: Almost all chronic pain in the lower back occurs in a six-by-four-inch area. Pain in the lower back occurs in the area where the lumbar vertebrae join the sacrum and the iliac crest.

Almost all chronic pain in the lower back occurs in a six-by-four inch area. Pain in the lower back occurs in the area where the lumbar vertebrae join the sacrum and the iliac crest.


Ninety-five percent of low back pain is located in a six-by-four-inch area, the weakest link in the vertebral-pelvis complex.

At the end of the spine, four structures connect in a very small, compacted space, a six-by-four-inch area. The fifth lumbar vertebra connects with the base of the sacrum. This is held together by the lumbosacral ligaments. The sacrum is connected on its sides to the ilium and iliac crest. This is held together by the sacroiliac ligaments. The lumbar vertebrae are held to the iliac crest and ilium by the iliolumbar ligaments.

Lumbar instability begins when the stabilizing structures of the spine, especially the ligaments can no longer hold adjacent bones together. When present, this is termed mechanical instability. The term functional instability is used when mechanical instability causes symptoms with a certain function or activity (like those described above). Many people are walking around with mechanical instability but are asymptomatic because the force required to perform current normal activities is not beyond the ligaments and muscles’ ability and strength to perform these functions.

The question of PRP treatments should therefore mostly focus on PRP’s ability to address spinal instability and not disc height as the cause of lower back pain.

PRP, low back pain, and Iliolumbar syndrome

One of the reasons that the disc injection will have limited benefit is because for many patients it is not an “into the disc” fix. What are we seeing in this image? Spinal, hip, and pelvic ligaments.

In this image, we see the front of the pelvis and the many ligament attachments that hold the two halves of the pelvis together and connect the pelvis to the lumbar. When you look at the pelvic/spinal ligaments you can see how the spine and pelvic and spinal instability should not be treated in isolation. In this image, we see how the intertransverse ligament, anterior longitudinal ligament, anterior sacroiliac ligaments, iliolumbar ligaments, and pubofemoral ligaments all interact to provide a “firm girdle.” Injecting PRP into the lumbar discs and its subsequent failure can be seen as a problem of fixing a flat tire but not repairing the axle that holds the tire to the car. Instability in the axel will cause wear to the same area of the tire that leads to the leak that flattened the disc in the first place.

In this illustration we demonstrate the positioning and importance of the pelvic, hip, and spinal ligaments

In a December 2020 study (15), doctors at the VMMC Medical College and Hospital in New Delhi suggested that low back pain could be treated with PRP if the cause of the back pain could be identified as coming from a correct source. In the case of this paper, that source would be the iliolumbar syndrome and the iliolumbar ligaments. Here we have a treatment suggestion for the use of PRP that has nothing to do with treating discs in helping a patient with low back pain. Here are the summary highlights of this research

  • Iliolumbar syndrome is a frequent cause of chronic nonspecific low back pain. The cornerstone of its treatment lies in the specific diagnosis of the iliolumbar syndrome. The ultrasound-guided interventions have the potential for the specific diagnosis and treatment of the iliolumbar syndrome.
  • The study comprised fifty-seven patients with nonspecific low back pain with clinically suspected iliolumbar syndrome.
  • Two-staged ultrasound-guided interventions were performed: Primary diagnostic and secondary therapeutic interventions.

The patients in this study were first given a mild temporary numbing agent in the pelvic region to help determine the accuracy of diagnosis of the iliolumbar syndrome. Once determined PRP injections under ultrasound were next introduced.

Study results:

  • Ultra-sound PRP was injected in forty-five confirmed patients with iliolumbar syndrome.
  • Out of forty-five patients, forty-two patients showed significant clinico-radiological improvement.
  • There was a statistically significant reduction in low back pain scores after PRP injection.

PRP treatments for lower back pain

As stated earlier in this article, we do not offer PRP as a stand-alone treatment or would consider a single injection into the area of back pain a PRP treatment. A 2019 paper (16) however did find that “PRP therapy is a highly effective method for treatment of patients with isolated facet syndrome caused by degenerative diseases of the facet joints. Clinical efficacy is confirmed by the persistent significant reduction of pain symptoms and restoration of functional status in the early and late postoperative periods with low risks of adverse outcomes.”

In a recent paper, (17) doctors looked at 19 patients with lumbar facet joint syndrome who received lumbar facet joint injections with autologous PRP under x-ray fluoroscopic guidance.

Patients were followed up immediately, at one week, one month, 2 months, and 3 months following treatment, and progress was measured with a series of standardized scoring systems.

  • One week after treatment, low back pain was reduced significantly
    • The outcomes were assessed as “good” or “excellent” for 9 patients (47.37%) immediately after treatment,
    • 14 patients (73.68%) at one week,
    • 15 patients (78.95%) at one month,
    • 15 patients (78.95%) at 2 months,
    • and 15 patients (78.95%) at 3 months.

In the short-term period of 3 months, the new technique of lumbar facet joint injection with autologous PRP is effective and safe for patients with lumbar facet joint syndrome.

Our own observations as we approach three decades of medical care is that PRP would work better in many patients if it were combined with Prolotherapy treatments.

PRP and Prolotherapy treatments

A February 2022 study (18) examined the effect of platelet-rich plasma injections for chronic nonspecific low back pain: Then the researchers examined what happened when you treated patients with PRP and Prolotherapy.

The researchers of this study suggested that some patients suffer from chronic nonspecific low back pain that can be attributed to weakened ligaments. They also suggest that Prolotherapy is an effective treatment but its use remains controversial. These ligaments can also be strengthened by platelet-rich plasma injection. The researchers then hypothesized that the effectiveness of platelet-rich plasma injection and prolotherapy may decrease pain and improve the disability of patients with chronic low back pain.

  • Thirty-four patients with chronic nonspecific low back pain (duration of at least 3 months) and non-responsive to conventional management were randomized to platelet-rich plasma injection and lidocaine injection. Patients were treated with weekly platelet-rich plasma or lidocaine injections at the lumbopelvic ligaments for 2 weeks and then weekly prolotherapy with 15% glucose for 2 weeks and followed up for 6 months.

Results: “In chronic nonspecific low back pain, the platelet-rich plasma injection in combination with prolotherapy is an effective intervention and either lidocaine or platelet-rich plasma injection significantly reduced disability. And injection at the lumbopelvic ligaments using the platelet-rich plasma and prolotherapy is also an effective treatment for pain.”

Prolotherapy injections

Prolotherapy strengthens the lumbar vertebral ligaments and prevents the progressive degeneration that occurs with age to the intervertebral discs. A patient with chronic low back pain is typically treated with Prolotherapy injections into the insertions of the lumbosacral, iliolumbar, and sacroiliac ligaments. The initial assessment may reveal that the chronic low back pain and referred leg pain may be caused by a referred pain from other areas such as the pubic symphysis, hip joint, ischial tuberosity, sacrospinous, and sacrotuberous ligaments. Therefore, these areas are also examined.

For more information on the combined use of PRP and Prolotherapy please see Prolotherapy treatments for lumbar instability and low back pain.

Questions about our treatments?

If you have questions about your pain and how we may be able to help you, please contact us and get help and information from our Caring Medical staff.

 

Subscribe to our newsletter 

1 Jayasoorya A, Samal N, Pisulkar G, Datta K, Kawde K. Injections of Platelet-Rich Plasma: An Emerging Novel Biological Cure for Low Back Pain?. Cureus. 2024 Feb 12;16(2). [Google Scholar]
2 Machado ES, Soares FP, Vianna de Abreu E, de Souza TA, Meves R, Grohs H, Ambach MA, Navani A, de Castro RB, Pozza DH, Caldas JM. Systematic review of platelet-rich plasma for low back pain. Biomedicines. 2023 Aug 28;11(9):2404. [Google Scholar]
3 Xuan Z, Yu W, Dou Y, Wang T. Efficacy of Platelet-rich Plasma for Low Back Pain: A Systematic Review and Meta-analysis [published online ahead of print, 2020 May 21]. J Neurol Surg A Cent Eur Neurosurg. 2020;10.1055/s-0040-1709170. doi:10.1055/s-0040-1709170 [Google Scholar]
4 Kotb SY, Sherif NM, Saleh HA, Ahmed SF, Sakr HM, Taeimah MO. The role of intra-articular injection of autologous platelet-rich plasma versus corticosteroids in the treatment of synovitis in lumbar facet joint disease. Saudi medical journal. 2022 Nov 1;43(11):1200-8. [Google Scholar]
5 Demirci AY. The retrospective analysis of platelet-rich plasma and corticosteroid injection under epiduroscopic guidance for radiculopathy in operated or unoperated patients for lumbar disc herniation. Turkish Journal of Physical Medicine & Rehabilitation (2587-1250). 2022 Jul 1;68(3). [Google Scholar]
6 Grossen AA, Lee BJ, Shi HH, Shakir HJ, Cornett EM, Kaye AD. Platelet-rich plasma injections: pharmacological and clinical considerations in pain management. Current Pain and Headache Reports. 2022 Oct;26(10):741-9. [Google Scholar]
7 Xu Z, Wu S, Li X, Liu C, Fan S, Ma C. Ultrasound-Guided Transforaminal Injections of Platelet-Rich Plasma Compared with Steroid in Lumbar Disc Herniation: A Prospective, Randomized, Controlled Study. Neural Plasticity. 2021 May 27;2021. [Google Scholar]
8 Wongjarupong A, Pairuchvej S, Laohapornsvan P, Kotheeranurak V, Jitpakdee K, Yeekian C, Chanplakorn P. “Platelet-Rich Plasma” epidural injection an emerging strategy in lumbar disc herniation: a Randomized Controlled Trial. BMC Musculoskeletal Disorders. 2023 Dec;24(1):1-7. [Google Scholar]
9 Gupta A, Chhabra HS, Singh V, Nagarjuna D. Lumbar Transforaminal Injection of Steroids versus Platelet-Rich Plasma for Prolapse Lumbar Intervertebral Disc with Radiculopathy: A Randomized Double-Blind Controlled Pilot Study. Asian Spine Journal. 2024 Feb;18(1):58. [Google Scholar]
10 Baig MZ, Abdullah UE, Muhammad A, Aziz A, Syed MJ, Darbar A. Use of platelet-rich plasma in treating low back pain: A review of the current literature. Asian spine journal. 2021 Feb;15(1):117. [Google Scholar]
11 Zhang J, Liu D, Gong Q, Chen J, Wan L. Intradiscal autologous platelet-rich plasma injection for discogenic low back pain: A clinical trial. BioMed Research International. 2022 Oct 10;2022. [Google Scholar]
12 Singh GK, Talawar P, Kumar A, Sharma RS, Purohit G, Bhandari B. Effect of autologous platelet-rich plasma (PRP) on low back pain in patients with prolapsed intervertebral disc: A randomised controlled trial. Indian Journal of Anaesthesia. 2023 Mar 1;67(3):277-82. [Google Scholar]
13 Saraf A, Hussain A, Sandhu AS, Bishnoi S, Arora V. Transforaminal Injections of Platelet-Rich Plasma Compared with Steroid in Lumbar radiculopathy: A Prospective, Double-Blind Randomized Study. Indian Journal of Orthopaedics. 2023 May 5:1-8. [Google Scholar]
14 Darrow M, Shaw B, Nicholas S, Li X, Boeger G. Treatment of unresolved lower back pain with platelet-rich plasma injections. Cogent Medicine. 2019 Jan 1;6(1):1581449. [Google Scholar]
15 Nayak BK, Singh DK, Kumar N, Jaiswal B. Recovering from nonspecific low back pain despair: Ultrasound-guided intervention in iliolumbar syndrome. The Indian Journal of Radiology & Imaging. 2020 Oct;30(4):448. [Google Scholar]
16 Byvaltsev VA, Kalinin AA, Okoneshnikova AK, Satardinova EE. Analysis of the clinical efficacy of platelet-rich plasma therapy in the treatment of patients with isolated facet-syndrome of the lumbar spine. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2019 Jan 1;119(11):27-31. [Google Scholar]
17 Wu J, Du Z, Lv Y, Zhang J, Xiong W, Wang R, Liu R, Zhang G, Liu Q. A new technique for the treatment of lumbar facet joint syndrome using intra-articular injection with autologous platelet rich plasma. Pain physician. 2016 Nov 1;19(8):617-25. [Google Scholar]
18 Won SJ, Kim DY, Kim JM. Effect of platelet-rich plasma injections for chronic nonspecific low back pain: A randomized controlled study. Medicine. 2022 Feb 25;101(8).  [Google Scholar]


This article was updated March 28, 2024

Get Help Now!

You deserve the best possible results from your treatment. Let’s make this happen! Talk to our team about your case to find out if you are a good candidate.